Skip to main content
. 2021 Oct 27;9(6):e00886. doi: 10.1002/prp2.886

FIGURE 5.

FIGURE 5

Jadomycin proposed mechanisms of action in breast cancer cells. (A) Some jadomycins are copper‐dependent and convert Cu(II) to Cu(I), leading to the production of ROS and subsequent DNA damage. 8 , 12 (B) The DNA damage induced by jadomycins inhibits ABK and prevents mitosis and proliferation of breast cancer cells. 7 (C) Jadomycins B, S, and F have also demonstrated the ability to inhibit or poison topoisomerase II, which leads to further DNA damage and apoptosis. 7 Image created with BioRender.com